Chan Heng Fai Ambrose Insider Trading -- Recent SEC Form 4 Transactions

Chan Heng Fai Ambrose (CIK 1261725) reported 35 SEC Form 4 insider transactions across 5 companies over the past 18 months (most recent 2026-06-09). Recent activity: Buy HWH (250,000 shares), Buy HWH (1.0M shares), Sell AEI (500,000 shares), Buy DSS (130,679 shares), Buy AEI (33,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-09HWH International Inc. (HWH)Chief Executive OfficerBuy250,000$500,000
2025-12-01HWH International Inc. (HWH)Chief Executive OfficerBuy1.0M$0
2025-09-16Alset Inc. (AEI)Chief Executive OfficerSell500,000$1.3M
2025-09-02DSS, INC. (DSS)DirectorBuy130,679$176,417
2025-08-19Alset Inc. (AEI)Chief Executive OfficerBuy33,000$42,570
2025-07-23Alset Inc. (AEI)Chief Executive OfficerBuy27.7M$0
2025-07-02Alset Inc. (AEI)Chief Executive OfficerBuy280,000$0
2025-04-17Alset Inc. (AEI)Chief Executive OfficerBuy1.0M$0
2025-04-07IMPACT BIOMEDICAL INC. (IBO)DirectorSell351,555$175,778
2025-04-04IMPACT BIOMEDICAL INC. (IBO)DirectorSell300,000$174,000
2025-04-04IMPACT BIOMEDICAL INC. (IBO)DirectorSell200,000$134,000
2025-04-04IMPACT BIOMEDICAL INC. (IBO)DirectorSell2,349$1,574
2025-04-04IMPACT BIOMEDICAL INC. (IBO)DirectorSell382,427$221,808
2025-04-04IMPACT BIOMEDICAL INC. (IBO)DirectorSell351,631$203,946
2025-04-04IMPACT BIOMEDICAL INC. (IBO)DirectorSell273,286$213,163
2025-04-04IMPACT BIOMEDICAL INC. (IBO)DirectorSell180,000$172,800
2025-04-02IMPACT BIOMEDICAL INC. (IBO)DirectorSell400,000$392,000
2025-04-02IMPACT BIOMEDICAL INC. (IBO)DirectorSell300,000$309,000
2025-04-02IMPACT BIOMEDICAL INC. (IBO)DirectorSell650,000$942,500
2025-04-02IMPACT BIOMEDICAL INC. (IBO)DirectorSell1.2M$1.3M
2025-03-20SHARING SERVICES GLOBAL Corp (SHRG)DirectorBuy1,108$3,258
2025-03-20SHARING SERVICES GLOBAL Corp (SHRG)DirectorBuy1,772$5,387
2025-03-20SHARING SERVICES GLOBAL Corp (SHRG)DirectorBuy476$1,537
2025-03-20SHARING SERVICES GLOBAL Corp (SHRG)DirectorBuy171$537
2025-03-13HWH International Inc. (HWH)DirectorBuy69,444$0

Source: SEC Form 4 filings · as of 2026-06-09